GlassScriptPhysician profile
Melissa E Clayton
NPI 1568021590
$2,114.98
in general payments reported to CMS, 2019-2025
18 companies · $82.15 in 2025
The $82.15 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $494 · 2022: $562 · 2023: $626 · 2024: $351 · 2025: $82.15.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,059.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,059.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Relievant Medsystems, INC. | $681.20 | 2022-2023 | Intracept |
| Collegium Pharmaceutical, INC. | $240.23 | 2021-2023 | Belbuca, Xtampza |
| Abbvie INC. | $237.72 | 2022-2024 | |
| Boston Scientific Corporation | $199.79 | 2022-2024 | Intracept, Wavewriter Alpha Prime 16 |
| Scilex Pharmaceuticals INC. | $186.16 | 2021-2024 | Ztlido |
| Abbott Laboratories | $147.07 | 2021 | |
| Allergan, INC. | $106.33 | 2021-2022 | |
| Spinal Simplicity, LLC | $82.15 | 2025 | Ha Minuteman G3-R |
| Painteq LLC | $54.20 | 2024 | Painteq |
| Spr Therapeutics, INC | $27.04 | 2024 | Sprint Pns System |
| Nevro Corp. | $25.27 | 2023 | Senza |
| Arbor Pharmaceuticals, INC. | $23.69 | 2021 | |
| Depuy Synthes Sales INC. | $20.66 | 2024 | Orthovisc |
| Biodelivery Sciences International, INC. | $19.77 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $19.51 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ibsa Pharma INC. | $18.11 | 2021 | |
| Janssen Pharmaceuticals, INC | $14.09 | 2024 | Spravato |
| Kowa Pharmaceuticals America, INC. | $11.99 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Clayton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.